Protagonist Therapeutics Inc buy Capital One Financial Co.
Start price
30.10.23
/
50%
€21.80
Target price
30.10.24
€30.16
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 30.10.24. The prediction end date can be changed by Capital_One_Financia at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Protagonist Therapeutics Inc | - | - |
iShares Core DAX® | 0.238% | -2.265% |
iShares Nasdaq 100 | -0.304% | 5.808% |
iShares Nikkei 225® | 2.271% | 1.577% |
iShares S&P 500 | -0.296% | 4.447% |
Comments by Capital_One_Financia for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat